Using QALYs in telehealth evaluations: a systematic review of methodology and transparency
暂无分享,去创建一个
[1] S. Bae,et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? , 2010, Health economics.
[2] K. Muir,et al. Cost Effectiveness and Resource Allocation Open Access Comparing the Performance of the Eq-5d and Sf-6d When Measuring the Benefits of Alleviating Knee Pain Background , 2009 .
[3] Stavros Petrou,et al. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting , 2011, BMJ : British Medical Journal.
[4] K. Rabe,et al. Cost-Effectiveness of Internet-Based Self-Management Compared with Usual Care in Asthma , 2011, PloS one.
[5] T. Reardon,et al. Research findings and strategies for assessing telemedicine costs. , 2005, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
[6] Adrian G. Barnett,et al. Cost-Effectiveness of a Telephone-Delivered Intervention for Physical Activity and Diet , 2009, PloS one.
[7] A. Scott,et al. Valuing Benefits to Inform a Clinical Trial in Pharmacy , 2013, PharmacoEconomics.
[8] M. Neyt,et al. Threshold values for cost-effectiveness in health care KCE reports , 2009 .
[9] A. Kasuya. EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.
[10] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[11] Nick Kontodimopoulos,et al. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[12] J. Brazier,et al. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D , 2003, Health and quality of life outcomes.
[13] M. Suarez‐Almazor,et al. Variation in the Estimation of Quality‐adjusted Life‐years by Different Preference‐based Instruments , 2003, Medical care.
[14] George Tomlinson,et al. Predicting EQ-5D Utility Scores from the Seattle Angina Questionnaire in Coronary Artery Disease , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[15] B. O'brien,et al. The death of cost-minimization analysis? , 2001, Health economics.
[16] P. Hebert,et al. Cost-Effectiveness of Nurse-Led Disease Management for Heart Failure in an Ethnically Diverse Urban Community , 2008, Annals of Internal Medicine.
[17] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[18] Mark Leys,et al. Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions , 2011, International Journal of Technology Assessment in Health Care.
[19] Paul F. M. Krabbe,et al. Kwaliteit van leven meten in economische evaluaties: het Nederlands EQ-5D-tarief , 2005 .
[20] F. Smit,et al. Economic Evaluation of Internet-Based Interventions for Harmful Alcohol Use Alongside a Pragmatic Randomized Controlled Trial , 2012, Journal of medical Internet research.
[21] F. Pang,et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. , 2004, Health technology assessment.
[22] M. Sculpher,et al. Measuring costs and consequences in economic evaluation in asthma. , 2003, Respiratory medicine.
[23] G. Wills,et al. A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue. , 2012, Behaviour research and therapy.
[24] G. Guyatt,et al. Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.
[25] A. Parker,et al. Cost-Effectiveness of an Intervention to Reduce Emergency Re-Admissions to Hospital among Older Patients , 2009, PloS one.
[26] David Parkin,et al. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. , 2004, Health economics.
[27] Martin Knapp,et al. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial , 2013, BMJ.
[28] Marthe R. Gold,et al. Mapping the SF-12 to Preference-Based Instruments: Convergent Validity in a Low-Income, Minority Population , 2003, Medical care.
[29] J. Cairns,et al. SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility , 2009, The European Journal of Health Economics.
[30] E. Wouters,et al. Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: results of a randomised controlled trial , 2007, Cost effectiveness and resource allocation : C/E.
[31] I. Hendriksen,et al. Economic evaluation of a weight control program with e-mail and telephone counseling among overweight employees: a randomized controlled trial , 2012, International Journal of Behavioral Nutrition and Physical Activity.
[32] Karl Claxton,et al. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence , 2007, Journal of health services research & policy.
[33] Matthew L Maciejewski,et al. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. , 2010, Archives of general psychiatry.
[34] Alison Bowes,et al. Effectiveness of telemedicine: A systematic review of reviews , 2010, Int. J. Medical Informatics.
[35] E. Yeoh,et al. Measuring and preventing potentially avoidable hospital readmissions: a review of the literature. , 2010, Hong Kong medical journal = Xianggang yi xue za zhi.
[36] L. Yardley,et al. Clinical and cost effectiveness of booklet based vestibular rehabilitation for chronic dizziness in primary care: single blind, parallel group, pragmatic, randomised controlled trial , 2012, BMJ : British Medical Journal.
[37] M. Drummond,et al. Economic Evaluation in Health Care: Merging Theory with Practice , 2002 .
[38] S. Bryan,et al. Systematic Review and Empirical Comparison of Contemporaneous EQ-5D and SF-6D Group Mean Scores , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[39] A. Tosteson,et al. Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. , 2007, PharmacoEconomics.
[40] M. Drummond. Introducing economic and quality of life measurements into clinical studies , 2001, Annals of medicine.
[41] R. Wootton. Twenty years of telemedicine in chronic disease management – an evidence synthesis , 2012, Journal of telemedicine and telecare.
[42] Andrea Manca,et al. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. , 2004, Health economics.
[43] Oliver Rivero-Arias,et al. Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[44] I. Autti-Rämö,et al. QUALITY-ADJUSTED LIFE-YEARS FOR THE ESTIMATION OF EFFECTIVENESS OF SCREENING PROGRAMS: A SYSTEMATIC LITERATURE REVIEW , 2012, International Journal of Technology Assessment in Health Care.
[45] S. J. Whitehead,et al. Health outcomes in economic evaluation: the QALY and utilities. , 2010, British medical bulletin.
[46] M. Sculpher,et al. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. , 2005, Health economics.
[47] Trine S Bergmo,et al. Economic evaluation in telemedicine – still room for improvement , 2010, Journal of telemedicine and telecare.
[48] S. Palmer,et al. Definitions of efficiency , 1999, BMJ.
[49] R. Goeree,et al. A review of health utilities across conditions common in paediatric and adult populations , 2010, Health and quality of life outcomes.
[50] U. Björnstig,et al. A cost-utility analysis of nursing intervention via telephone follow-up for injured road users , 2009, BMC health services research.
[51] H. Sintonen. The 15D instrument of health-related quality of life: properties and applications , 2001, Annals of medicine.
[52] D J Torgerson,et al. Economic notes: definitions of efficiency. , 1999, BMJ.
[53] Y. Tountas,et al. Comparing SF-6D and EQ-5D utilities across groups differing in health status , 2009, Quality of Life Research.
[54] John E. Brazier,et al. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D , 2005, Quality of Life Research.
[55] M. Drummond,et al. Using QALYs in Cancer: A Review of the Methdological Limitations , 2010 .
[56] R M Kaplan,et al. A general health policy model: update and applications. , 1988, Health services research.
[57] H. Mistry. Systematic review of studies of the cost-effectiveness of telemedicine and telecare. Changes in the economic evidence over twenty years , 2012, Journal of telemedicine and telecare.
[58] R. Beyth,et al. The cost-utility of a care coordination/home telehealth programme for veterans with diabetes , 2007, Journal of telemedicine and telecare.
[59] P. Lambin,et al. Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. , 2011, European journal of cancer.
[60] J. Brazier,et al. The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.
[61] P. Bower,et al. Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial , 2013, BMJ : British Medical Journal.
[62] Johannes Brug,et al. Cost-effectiveness of tailored print communication, telephone motivational interviewing, and a combination of the two: results of an economic evaluation alongside the Vitalum randomized controlled trial , 2010, The international journal of behavioral nutrition and physical activity.
[63] M. Drummond,et al. Using QALYs in Cancer , 2012, PharmacoEconomics.
[64] J. Brazier,et al. The Estimation of a Preference-Based Measure of Health From the SF-12 , 2004, Medical care.
[65] P. Stalmeier,et al. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. , 2006, Health economics.
[66] Trine S Bergmo,et al. Can economic evaluation in telemedicine be trusted? A systematic review of the literature , 2009, Cost effectiveness and resource allocation : C/E.
[67] Grazyna Adamiak,et al. Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .
[68] A. While,et al. Telephone follow‐up to improve glycaemic control in patients with Type 2 diabetes: systematic review and meta‐analysis of controlled trials , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[69] J. Seidell,et al. Oral nutritional support in malnourished elderly decreases functional limitations with no extra costs. , 2012, Clinical nutrition.
[70] T. Albert,et al. Cost-utility analysis in spine care: a systematic review. , 2012, The spine journal : official journal of the North American Spine Society.
[71] D. Schillinger,et al. Cost-Effectiveness of Automated Telephone Self-Management Support With Nurse Care Management Among Patients With Diabetes , 2008, The Annals of Family Medicine.
[72] J. Karnon,et al. A systematic review of economic analyses of telehealth services using real time video communication , 2010, BMC health services research.
[73] Brad Smith,et al. Cost-effectiveness of telephonic disease management in heart failure. , 2008, The American journal of managed care.
[74] K. Muir,et al. Comparing Cost-Utility Estimates: Does the Choice of EQ-5D or SF-6D Matter? , 2009, Medical care.
[75] P. Stalmeier,et al. [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]. , 2005, Nederlands tijdschrift voor geneeskunde.
[76] M Sculpher,et al. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. , 2004, Health technology assessment.
[77] R. Kaplan. The Minimally Clinically Important Difference in Generic Utility-Based Measures , 2005, COPD.
[78] M. Soares. Is the QALY blind, deaf and dumb to equity? NICE's considerations over equity. , 2012, British medical bulletin.
[79] J. Thumboo,et al. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. , 2007, Arthritis and rheumatism.
[80] R. Osborne,et al. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of Health-Related Quality of Life , 1999, Quality of Life Research.